10x Genomics (TXG) Inventory Average (2019 - 2026)

10x Genomics (TXG) has 8 years of Inventory Average data on file, last reported at $54.9 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average fell 30.41% year-over-year to $54.9 million; the trailing twelve-month figure through Mar 2026 stood at $54.9 million (down 30.41% YoY), and the FY2025 full-year result was $69.7 million, down 11.07% from the prior year.
• Inventory Average declined to $54.9 million in Q1 2026, from $59.1 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $91.2 million in Q3 2024 to a low of $54.9 million in Q1 2026.
• A 5-year average of $75.4 million and a median of $78.4 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average jumped 80.62% in 2022 and tumbled 33.22% in 2025, its largest moves.
• Tracing TXG's Inventory Average over 5 years: stood at $80.1 million in 2022, then declined by 3.52% to $77.3 million in 2023, then advanced by 14.57% to $88.6 million in 2024, then plunged by 33.22% to $59.1 million in 2025, then declined by 7.16% to $54.9 million in 2026.
• Business Quant data shows TXG's Inventory Average at $54.9 million in Q1 2026, $59.1 million in Q4 2025, and $65.5 million in Q3 2025.